Загрузка...
Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants
BACKGROUND: Trivalent inactivated influenza vaccine (TIV) is not licensed for use in infants <6 months old, the group with the highest influenza hospitalization rates among children. METHODS: In this prospective, open-label study, 2 doses of TIV were administered to healthy infants aged 10–22 wee...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3773726/ https://ncbi.nlm.nih.gov/pubmed/18444800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/587643 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|